( Bloomberg:NVP@SS, ISIN:SE0002575340, RICS:NVP.ST, Stockholm:NVP )

News from NeuroVive Pharmaceutical A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Nov 21, 2017, 02:42 ET NeuroVive Pharmaceutical AB Interim Report January - September 2017

Business operations Significant events July-September 2017 - NeuroVive received positive feedback from the European Medicines Agency...


Nov 15, 2017, 03:16 ET NeuroVive Presents TBI Clinical Study Results at Nordic Neurotrauma Conference

NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) today announced that the company will present data from its clinical phase IIa...


Nov 07, 2017, 02:40 ET NeuroVive Board Chair Resigns, New Chair Elected

NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) announces that Gregory Batcheller resigned as Chair of the NeuroVive...


Nov 03, 2017, 03:44 ET NeuroVive Conducts a Directed New Share Issue of SEK 5.3 Million

NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF), a leading company in mitochondrial medicine, announced today that the company...


Oct 31, 2017, 03:49 ET NeuroVive Signs Collaboration Agreement With University of Florida for TBI Biomarker Development

NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) today announced that the company has signed a collaboration agreement with Kevin...


Oct 18, 2017, 02:52 ET NeuroVive and Lund University Collaboration Receives Grant for Liver Cancer Research

NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF), the mitochondrial medicine company, today announced that NeuroVive and Ramin...


Oct 05, 2017, 03:07 ET NeuroVive's Collaborator, the Children's Hospital of Philadelphia Awarded NIH Grant to Study NVP015 Against Chemical Threats

NeuroVive Pharmaceutical AB (NASDAQ Stockholm: NVP, OTCQX: NEVPF), the mitochondrial medicine company, today announced that its research...


Oct 04, 2017, 02:49 ET NeuroVive Appoints Daniel Schale as Director of Communications

NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF), the mitochondrial medicine company, today announced the appointment of Daniel...


Jun 27, 2017, 04:58 ET NeuroVive and Yungjin Pharm Start Clinical Development in Genetic Mitochondrial Disease

NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) and Yungjin Pharm Corporation Ltd (South Korea Stock Market,...


Jun 01, 2017, 07:24 ET NeuroVive Receives Research Grant From Vinnova for Development of the NVP015 Genetic Mitochondrial Disease Project

NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) today announced that the company receives close to 1 million SEK in a research...


May 23, 2017, 02:48 ET NeuroVive to Continue NeuroSTAT® Clinical Development After Positive Outcome in Preclinical and Clinical TBI Studies

NeuroVive Pharmaceutical AB(Nasdaq Stockholm: NVP, OTCQX: NEVPF) today announced positive results from clinical and preclinical studies with its...


May 18, 2017, 03:01 ET NeuroVive Pharmaceutical AB Interim Report January - March 2017

Broadened project portfolio Business operations Significant events January-March 2017 - Strong inhibitory effects demonstrated in...


May 02, 2017, 02:44 ET NeuroVive Invitation to Conference Call and Web Cast on in-licensing Agreement With Yungjin Pharm

NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) ("NeuroVive") invites to a conference call and webcast tomorrow, 3 May 2017, at...


May 01, 2017, 23:27 ET NeuroVive in-licenses a Genetic Mitochondrial Disease Clinical Stage Project From Yungjin Pharm

NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) and Yungjin Pharm Corporation Ltd (South Korea Stock Market, KRX 003520) today...


Apr 20, 2017, 02:42 ET NeuroVive Presents Preclinical Findings of NV556 in NASH Showing Confirmatory Anti-fibrotic Effects

NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) ("NeuroVive") today announced positive preclinical results demonstrating...


Apr 05, 2017, 04:26 ET NeuroVive's Lead NASH Project to be Presented at The International Liver Congress™

NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF), the mitochondrial medicine company, today announced that an abstract with...


Mar 31, 2017, 07:08 ET Number of Shares and Votes in NeuroVive Pharmaceutical AB (publ)

NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF), the mitochondrial medicine company, today announced an increase of the number...


Mar 23, 2017, 04:06 ET NeuroVive Pharmaceutical AB Publishes 2016 Annual Report

NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF), the mitochondrial medicine company, today announced that the English version of...


Mar 23, 2017, 03:49 ET Notice of Annual General Meeting of Shareholders in NeuroVive Pharmaceutical AB

The Board of Directors of NeuroVive Pharmaceutical AB (publ) has issued a notice to the Annual General Meeting, which is to take place on...


Feb 22, 2017, 04:56 ET NeuroVive Appoints Recognized Scientific Advisors and Enters Research Agreements in NASH and Hepatocellular Carcinoma

NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF), the mitochondrial medicine company, today announced two new research agreements...


Feb 21, 2017, 02:41 ET NeuroVive Pharmaceutical AB Year End Report January - December 2016

Important steps forward and new research collaborations Business operations Important events October – December 2016 • The development of...


Feb 02, 2017, 02:57 ET NeuroVive's new Generation of Sanglifehrin-based Compounds Demonstrate Potent Inhibitory Effects on Human Hepatocellular Cancer Cells

NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF), the mitochondrial medicine company, presents preclinical data from a new...


Jan 25, 2017, 02:40 ET NeuroVive Redirects Research Resources From Asian Subsidiary to Parent

NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF), the mitochondrial medicine company, today announced that its Taiwan-based...


Jan 23, 2017, 02:41 ET NeuroVive Signs Mitochondrial Medicine Research Agreement With US key Opinion Leader

NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF), today announces that NeuroVive has signed a preclinical collaboration agreement...


Jan 19, 2017, 04:30 ET NeuroVive Presents Positive Preclinical Data in Hepatocellular Cancer at HCC Summit

NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF), the mitochondrial medicine company, today announced that an abstract with novel...